: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription

Articles published in PLoS One
Retrieve available abstracts of 462 articles:
HTML format
Text format

Single Articles

January 2018

CHEN WC, Su VY, Yu WK, Chen YW, et al
Prognostic factors of noninvasive mechanical ventilation in lung cancer patients with acute respiratory failure.
PLoS One. 2018;13:e0191204.
PubMed Text format Abstract available

Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
PLoS One. 2018;13:e0191454.
PubMed Text format Abstract available

CHUANG MC, Yang YH, Tsai YH, Hsieh MJ, et al
Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study.
PLoS One. 2018;13:e0191129.
PubMed Text format Abstract available

BELQAID K, Tishelman C, Orrevall Y, Mansson-Brahme E, et al
Dealing with taste and smell alterations-A qualitative interview study of people treated for lung cancer.
PLoS One. 2018;13:e0191117.
PubMed Text format Abstract available

PARK S, Ha S, Lee SH, Paeng JC, et al
Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor.
PLoS One. 2018;13:e0189766.
PubMed Text format Abstract available

SHIN DW, Chun S, Kim YI, Kim SJ, et al
A national survey of lung cancer specialists' views on low-dose CT screening for lung cancer in Korea.
PLoS One. 2018;13:e0192626.
PubMed Text format Abstract available

KILVAER TK, Rakaee M, Hellevik T, Ostman A, et al
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
PLoS One. 2018;13:e0192157.
PubMed Text format Abstract available

KIRIU T, Yamamoto M, Nagano T, Hazama D, et al
The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer.
PLoS One. 2018;13:e0193018.
PubMed Text format Abstract available

HOVANEC J, Siemiatycki J, Conway DI, Olsson A, et al
Lung cancer and socioeconomic status in a pooled analysis of case-control studies.
PLoS One. 2018;13:e0192999.
PubMed Text format Abstract available

PAK K, Kim K, Kim MH, Eom JS, et al
A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.
PLoS One. 2018;13:e0193403.
PubMed Text format Abstract available

TAMIYA M, Tamiya A, Inoue T, Kimura M, et al
Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial.
PLoS One. 2018;13:e0192227.
PubMed Text format Abstract available

Correction: Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.
PLoS One. 2018;13:e0194257.
PubMed Text format Abstract available

CARVALHO S, Leijenaar RTH, Troost EGC, van Timmeren JE, et al
18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
PLoS One. 2018;13:e0192859.
PubMed Text format Abstract available

MALEKI VAREKI S, Salim KY, Danter WR, Koropatnick J, et al
Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines.
PLoS One. 2018;13:e0191766.
PubMed Text format Abstract available

HAN Y, Kim HJ, Kong KA, Kim SJ, et al
Diagnosis of small pulmonary lesions by transbronchial lung biopsy with radial endobronchial ultrasound and virtual bronchoscopic navigation versus CT-guided transthoracic needle biopsy: A systematic review and meta-analysis.
PLoS One. 2018;13:e0191590.
PubMed Text format Abstract available

ZHANG Z, Wang H, Ding Q, Xing Y, et al
Establishment of patient-derived tumor spheroids for non-small cell lung cancer.
PLoS One. 2018;13:e0194016.
PubMed Text format Abstract available

MIHOUB M, Pichette A, Sylla B, Gauthier C, et al
Bidesmosidic betulin saponin bearing L-rhamnopyranoside moieties induces apoptosis and inhibition of lung cancer cells growth in vitro and in vivo.
PLoS One. 2018;13:e0193386.
PubMed Text format Abstract available

BUHL IK, Santoni-Rugiu E, Ravn J, Hansen A, et al
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
PLoS One. 2018;13:e0194609.
PubMed Text format Abstract available

DEHUA Z, Mingming C, Jisheng W
Meta-analysis of gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer.
PLoS One. 2018;13:e0193814.
PubMed Text format Abstract available

CHANG WY, Wu YL, Su PL, Yang SC, et al
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.
PLoS One. 2018;13:e0192161.
PubMed Text format Abstract available

KIM CR, Kim EY, Kim YS, Ahn HK, et al
Histologic subtypes are not associated with the presence of sarcopenia in lung cancer.
PLoS One. 2018;13:e0194626.
PubMed Text format Abstract available

CHEN CH, Chang CK, Tu CY, Liao WC, et al
Radiomic features analysis in computed tomography images of lung nodule classification.
PLoS One. 2018;13:e0192002.
PubMed Text format Abstract available

FU M, Travier N, Martin-Sanchez JC, Martinez-Sanchez JM, et al
Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
PLoS One. 2018;13:e0195441.
PubMed Text format Abstract available

LEE EH, Park CH, Choi HJ, Kawala RA, et al
Dexamethasone modified by gamma-irradiation as a novel anticancer drug in human non-small cell lung cancer.
PLoS One. 2018;13:e0194341.
PubMed Text format Abstract available

ERNST AK, Putscher A, Samatov TR, Suling A, et al
Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.
PLoS One. 2018;13:e0192525.
PubMed Text format Abstract available

LIU K, Zheng D, Xu G, Du Z, et al
Correction: Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis.
PLoS One. 2018;13:e0196618.
PubMed Text format Abstract available

BISAGNI A, Pagano M, Maramotti S, Zanelli F, et al
Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients.
PLoS One. 2018;13:e0196350.
PubMed Text format Abstract available

CIRCU M, Cardelli J, Barr MP, O'Byrne K, et al
Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
PLoS One. 2018;13:e0197016.
PubMed Text format Abstract available

DEROUEN MC, Hu L, McKinley M, Gali K, et al
Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in California.
PLoS One. 2018;13:e0197146.
PubMed Text format Abstract available

EDELSBERG J, Weycker D, Atwood M, Hamilton-Fairley G, et al
Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.
PLoS One. 2018;13:e0197826.
PubMed Text format Abstract available

KIM H, Kwon HJ, Park SY, Park Y, et al
Clinicopathological analysis and prognostic significance of programmed cell death-ligand 1 protein and mRNA expression in non-small cell lung cancer.
PLoS One. 2018;13:e0198634.
PubMed Text format Abstract available

ZHANG X, Nakajima T, Kim M, Yamaguchi A, et al
Activatable fluorescence detection of epidermal growth factor receptor positive mediastinal lymph nodes in murine lung cancer model.
PLoS One. 2018;13:e0198224.
PubMed Text format Abstract available

WALTER RFH, Rozynek P, Casjens S, Werner R, et al
Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
PLoS One. 2018;13:e0195716.
PubMed Text format Abstract available

KIM KI, Jun JH, Baek H, Kim JH, et al
Oral administration of herbal medicines for radiation pneumonitis in lung cancer patients: A systematic review and meta-analysis.
PLoS One. 2018;13:e0198015.
PubMed Text format Abstract available

GU L, Wang Z, Zuo J, Li H, et al
Prognostic significance of NF-kappaB expression in non-small cell lung cancer: A meta-analysis.
PLoS One. 2018;13:e0198223.
PubMed Text format Abstract available

CHORNER PM, Moorehead RA
A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206.
PLoS One. 2018;13:e0193344.
PubMed Text format Abstract available

SILVA MA, Ryall KA, Wilm C, Caldara J, et al
PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters.
PLoS One. 2018;13:e0196464.
PubMed Text format Abstract available

HSIEH LY, Chou FJ, Guo SE
Information needs of patients with lung cancer from diagnosis until first treatment follow-up.
PLoS One. 2018;13:e0199515.
PubMed Text format Abstract available

DANISH L, Imig D, Allgower F, Scheurich P, et al
Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps.
PLoS One. 2018;13:e0198203.
PubMed Text format Abstract available

BLUME JD, D'Agostino McGowan L, Dupont WD, Greevy RA Jr, et al
Second-generation p-values: Improved rigor, reproducibility, & transparency in statistical analyses.
PLoS One. 2018;13:e0188299.
PubMed Text format Abstract available

PLAGNOL V, Woodhouse S, Howarth K, Lensing S, et al
Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.
PLoS One. 2018;13:e0193802.
PubMed Text format Abstract available

YANG M, Feng Y, Yue C, Xu B, et al
Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.
PLoS One. 2018;13:e0193428.
PubMed Text format Abstract available

FERRARINI A, Forcato C, Buson G, Tononi P, et al
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
PLoS One. 2018;13:e0193689.
PubMed Text format Abstract available

ROTH JA, Carter-Harris L, Brandzel S, Buist DSM, et al
A qualitative study exploring patient motivations for screening for lung cancer.
PLoS One. 2018;13:e0196758.
PubMed Text format Abstract available

HEIDEN BT, Chen G, Hermann M, Brown RKJ, et al
18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer.
PLoS One. 2018;13:e0199970.
PubMed Text format Abstract available

LIM JU, Yeo CD, Kang HS, Park CK, et al
Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.
PLoS One. 2018;13:e0200341.
PubMed Text format Abstract available

DUAN L, Ye L, Zhuang L, Zou X, et al
VEGFC/VEGFR3 axis mediates TGFbeta1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cells.
PLoS One. 2018;13:e0200452.
PubMed Text format Abstract available

LU X, Gao J, Zhang Y, Zhao T, et al
CTEN induces epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung cancer cells.
PLoS One. 2018;13:e0198823.
PubMed Text format Abstract available

PANNUTI A, Filipovic A, Hicks C, Lefkowitz E, et al
Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.
PLoS One. 2018;13:e0194790.
PubMed Text format Abstract available

January 2017

ZHANG Y, Xue Q, Pan G, Meng QH, et al
Integrated Analysis of Genome-Wide Copy Number Alterations and Gene Expression Profiling of Lung Cancer in Xuanwei, China.
PLoS One. 2017;12:e0169098.
PubMed Text format Abstract available

HUYNH E, Coroller TP, Narayan V, Agrawal V, et al
Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
PLoS One. 2017;12:e0169172.
PubMed Text format Abstract available

BEN-LULU S, Ziv T, Weisman-Shomer P, Benhar M, et al
Nitrosothiol-Trapping-Based Proteomic Analysis of S-Nitrosylation in Human Lung Carcinoma Cells.
PLoS One. 2017;12:e0169862.
PubMed Text format Abstract available

XIAO L, Liu N, Zhang G, Zhang H, et al
Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
PLoS One. 2017;12:e0170901.
PubMed Text format Abstract available

LOKK K, Vooder T, Kolde R, Valk K, et al
Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer.
PLoS One. 2017;12:e0170833.
PubMed Text format Abstract available

NATTENMULLER J, Wochner R, Muley T, Steins M, et al
Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.
PLoS One. 2017;12:e0169136.
PubMed Text format Abstract available

TAKASE Y, Usui K, Shimizu K, Kimura Y, et al
Highly sensitive detection of a HER2 12-base pair duplicated insertion mutation in lung cancer using the Eprobe-PCR method.
PLoS One. 2017;12:e0171225.
PubMed Text format Abstract available

HOU LK, Ma YS, Han Y, Lu GX, et al
Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy.
PLoS One. 2017;12:e0170431.
PubMed Text format Abstract available

WALKER R, Deppen S, Smith G, Shi C, et al
68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
PLoS One. 2017;12:e0171301.
PubMed Text format Abstract available

TSUCHIYA N, Doai M, Usuda K, Uramoto H, et al
Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion.
PLoS One. 2017;12:e0172433.
PubMed Text format Abstract available

AOKI N, Mochizuki K, Matsui Y
DNA methylation of the Fthl17 5'-upstream region regulates differential Fthl17 expression in lung cancer cells and germline stem cells.
PLoS One. 2017;12:e0172219.
PubMed Text format Abstract available

CHEN Y, Min L, Ren C, Xu X, et al
miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.
PLoS One. 2017;12:e0171751.
PubMed Text format Abstract available

SUDA K, Rozeboom L, Yu H, Ellison K, et al
Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status.
PLoS One. 2017;12:e0172209.
PubMed Text format Abstract available

HRADILOVA N, Sadilkova L, Palata O, Mysikova D, et al
Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.
PLoS One. 2017;12:e0171539.
PubMed Text format Abstract available

SOK SP, Arshad NM, Azmi MN, Awang K, et al
The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.
PLoS One. 2017;12:e0171329.
PubMed Text format Abstract available

KAWAZOE H, Yano A, Ishida Y, Takechi K, et al
Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study.
PLoS One. 2017;12:e0171066.
PubMed Text format Abstract available

HUNG MS, Chen IC, Lee CP, Huang RJ, et al
Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study.
PLoS One. 2017;12:e0171137.
PubMed Text format Abstract available

JIAO DM, Yan L, Wang LS, Hu HZ, et al
Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
PLoS One. 2017;12:e0172470.
PubMed Text format Abstract available

NARITA M, Shimura E, Nagasawa A, Aiuchi T, et al
Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.
PLoS One. 2017;12:e0172115.
PubMed Text format Abstract available

SHEN G, Lan Y, Zhang K, Ren P, et al
Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
PLoS One. 2017;12:e0173104.
PubMed Text format Abstract available

HOU PF, Zhu LJ, Chen XY, Qiu ZQ, et al
Age-related changes in CD4+CD25+FOXP3+ regulatory T cells and their relationship with lung cancer.
PLoS One. 2017;12:e0173048.
PubMed Text format Abstract available

HORIBE R, Hirohashi Y, Asano T, Mariya T, et al
Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.
PLoS One. 2017;12:e0171460.
PubMed Text format Abstract available

SHIN DW, Kim YI, Kim SJ, Kim JS, et al
Lung cancer specialist physicians' attitudes towards e-cigarettes: A nationwide survey.
PLoS One. 2017;12:e0172568.
PubMed Text format Abstract available

YIN J, Zhao J, Hu W, Yang G, et al
Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.
PLoS One. 2017;12:e0172787.
PubMed Text format Abstract available

SHEEHAN DF, Criss SD, Gazelle GS, Pandharipande PV, et al
Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach.
PLoS One. 2017;12:e0173119.
PubMed Text format Abstract available

ROSENBERGER A, Sohns M, Friedrichs S, Hung RJ, et al
Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus.
PLoS One. 2017;12:e0173339.
PubMed Text format Abstract available

YANG Y, Qiu S, Qian L, Tian Y, et al
OCF can repress tumor metastasis by inhibiting epithelial-mesenchymal transition involved in PTEN/PI3K/AKT pathway in lung cancer cells.
PLoS One. 2017;12:e0174021.
PubMed Text format Abstract available

RYUGE S, Sato Y, Nagashio R, Hiyoshi Y, et al
Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers.
PLoS One. 2017;12:e0173886.
PubMed Text format Abstract available

HOU GX, Liu P, Yang J, Wen S, et al
Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
PLoS One. 2017;12:e0174515.
PubMed Text format Abstract available

OGUMA T, Nagaoka T, Kurahashi M, Kobayashi N, et al
Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer.
PLoS One. 2017;12:e0174802.
PubMed Text format Abstract available

FAN L, Chen L, Ni X, Guo S, et al
Genetic variant of miR-4293 rs12220909 is associated with susceptibility to non-small cell lung cancer in a Chinese Han population.
PLoS One. 2017;12:e0175666.
PubMed Text format Abstract available

DAVIES J, Patel M, Gridelli C, de Marinis F, et al
Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies.
PLoS One. 2017;12:e0175679.
PubMed Text format Abstract available

SHEN G, Lan Y, Zhang K, Ren P, et al
Correction: Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
PLoS One. 2017;12:e0176150.
PubMed Text format Abstract available

HE M, Yang Z, Zhang L, Song C, et al
Additive effects of cherlerythrine chloride combination with erlotinib in human non-small cell lung cancer cells.
PLoS One. 2017;12:e0175466.
PubMed Text format Abstract available

SHIRAI K, Kawashima M, Saitoh JI, Abe T, et al
Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.
PLoS One. 2017;12:e0175589.
PubMed Text format Abstract available

CAO G, Cheng D, Ye L, Pan Y, et al
Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences.
PLoS One. 2017;12:e0175284.
PubMed Text format Abstract available

XU Z, Yan Y, Xiao L, Dai S, et al
Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway.
PLoS One. 2017;12:e0175977.
PubMed Text format Abstract available

INOUE Y, Shiihara J, Miyazawa H, Ohta H, et al
A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer.
PLoS One. 2017;12:e0176525.
PubMed Text format Abstract available

FUKUDA T, Nomura M, Kato Y, Tojo H, et al
A selected reaction monitoring mass spectrometric assessment of biomarker candidates diagnosing large-cell neuroendocrine lung carcinoma by the scaling method using endogenous references.
PLoS One. 2017;12:e0176219.
PubMed Text format Abstract available

BAILEY G, Healy A, Young BD, Sharma E, et al
Relative predictive value of lung cancer screening CT versus myocardial perfusion attenuation correction CT in the evaluation of coronary calcium.
PLoS One. 2017;12:e0175678.
PubMed Text format Abstract available

TAKAMOCHI K, Mogushi K, Kawaji H, Imashimizu K, et al
Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.
PLoS One. 2017;12:e0175622.
PubMed Text format Abstract available

DENEKA AY, Haber L, Kopp MC, Gaponova AV, et al
Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model.
PLoS One. 2017;12:e0176747.
PubMed Text format Abstract available

DURDA K, Kaklewski K, Gupta S, Szydlowski M, et al
Serum folate concentration and the incidence of lung cancer.
PLoS One. 2017;12:e0177441.
PubMed Text format Abstract available

KIM JS, Cho MS, Nam JH, Kim HJ, et al
Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer.
PLoS One. 2017;12:e0177015.
PubMed Text format Abstract available

JUN HY, Kim TH, Choi JW, Lee YH, et al
Evaluation of connectivity map-discovered celastrol as a radiosensitizing agent in a murine lung carcinoma model: Feasibility study of diffusion-weighted magnetic resonance imaging.
PLoS One. 2017;12:e0178204.
PubMed Text format Abstract available

HOLMBOE S, Hansen PL, Thisgaard H, Block I, et al
Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.
PLoS One. 2017;12:e0178286.
PubMed Text format Abstract available

PARK SL, Murphy SE, Wilkens LR, Stram DO, et al
Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
PLoS One. 2017;12:e0178435.
PubMed Text format Abstract available

CAMERON SJS, Lewis KE, Huws SA, Hegarty MJ, et al
A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer.
PLoS One. 2017;12:e0177062.
PubMed Text format Abstract available

CHANG HW, Lin ZM, Wu MJ, Wang LY, et al
Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype.
PLoS One. 2017;12:e0175586.
PubMed Text format Abstract available

CARRERAS-TORRES R, Johansson M, Haycock PC, Wade KH, et al
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study.
PLoS One. 2017;12:e0177875.
PubMed Text format Abstract available

CHANG YP, Chen YM, Lai CH, Lin CY, et al
The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.
PLoS One. 2017;12:e0178676.
PubMed Text format Abstract available

WEISS GJ, Byron SA, Aldrich J, Sangal A, et al
A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy.
PLoS One. 2017;12:e0179170.
PubMed Text format Abstract available

ABERNETHY AP, Arunachalam A, Burke T, McKay C, et al
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting.
PLoS One. 2017;12:e0178420.
PubMed Text format Abstract available

WU YT, Li X, Liu ZL, Xu Z, et al
Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.
PLoS One. 2017;12:e0179680.
PubMed Text format Abstract available

YAGI S, Koh Y, Akamatsu H, Kanai K, et al
Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients.
PLoS One. 2017;12:e0179744.
PubMed Text format Abstract available

BEN-LULU S, Ziv T, Weisman-Shomer P, Benhar M, et al
Correction: Nitrosothiol-Trapping-Based Proteomic Analysis of S-Nitrosylation in Human Lung Carcinoma Cells.
PLoS One. 2017;12:e0179803.
PubMed Text format Abstract available

SCHMIDT LH, Brand C, Stucke-Ring J, Schliemann C, et al
Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
PLoS One. 2017;12:e0177146.
PubMed Text format Abstract available

LOISELLE JJ, Roy JG, Sutherland LC
RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.
PLoS One. 2017;12:e0180258.
PubMed Text format Abstract available

DE MARCO C, Laudanna C, Rinaldo N, Oliveira DM, et al
Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
PLoS One. 2017;12:e0178865.
PubMed Text format Abstract available

LEE AF, Chen MC, Chen CJ, Yang CJ, et al
Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells.
PLoS One. 2017;12:e0180383.
PubMed Text format Abstract available

GUISIER F, Bohn P, Patout M, Piton N, et al
In- and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopy.
PLoS One. 2017;12:e0180576.
PubMed Text format Abstract available

POWELL AC, Mirhadi AJ, Loy BA, Happe LE, et al
Presentation at computed tomography (CT) scan of the thorax and first year diagnostic and treatment utilization among patients diagnosed with lung cancer.
PLoS One. 2017;12:e0181319.
PubMed Text format Abstract available

GOTO A, Tanaka M, Yoshida M, Umakoshi M, et al
The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.
PLoS One. 2017;12:e0181270.
PubMed Text format Abstract available

SAUSVILLE LN, Jones CC, Aldrich MC, Blot WJ, et al
Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival.
PLoS One. 2017;12:e0180471.
PubMed Text format Abstract available

LIU PL, Liu WL, Chang JM, Chen YH, et al
MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
PLoS One. 2017;12:e0180844.
PubMed Text format Abstract available

MESSARITAKIS I, Politaki E, Kotsakis A, Dermitzaki EK, et al
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.
PLoS One. 2017;12:e0181211.
PubMed Text format Abstract available

SILVA EM, Mariano VS, Pastrez PRA, Pinto MC, et al
High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer.
PLoS One. 2017;12:e0181125.
PubMed Text format Abstract available

TANG ZM, Ling ZG, Wang CM, Wu YB, et al
Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
PLoS One. 2017;12:e0182117.
PubMed Text format Abstract available

BANJARA M, Ghosh C, Dadas A, Mazzone P, et al
Detection of brain-directed autoantibodies in the serum of non-small cell lung cancer patients.
PLoS One. 2017;12:e0181409.
PubMed Text format Abstract available

SARIN N, Engel F, Kalayda GV, Mannewitz M, et al
Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
PLoS One. 2017;12:e0181081.
PubMed Text format Abstract available

PATNAIK SK, Kannisto ED, Mallick R, Vachani A, et al
Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.
PLoS One. 2017;12:e0181926.
PubMed Text format Abstract available

AL-SAAD S, Richardsen E, Kilvaer TK, Donnem T, et al
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.
PLoS One. 2017;12:e0181527.
PubMed Text format Abstract available

OH TK, Jeon JH, Lee JM, Kim MS, et al
Investigation of opioid use and long-term oncologic outcomes for non-small cell lung cancer patients treated with surgery.
PLoS One. 2017;12:e0181672.
PubMed Text format Abstract available

KOLEK V, Grygarkova I, Koubkova L, Skrickova J, et al
Carboplatin with intravenous and subsequent oral administration of vinorelbine in resected non-small-cell-lung cancer in real-world set-up.
PLoS One. 2017;12:e0181803.
PubMed Text format Abstract available

GONG X, Liu J, Zhang D, Yang D, et al
GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
PLoS One. 2017;12:e0182410.
PubMed Text format Abstract available

LIU L, He Y, Ge G, Li L, et al
Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study.
PLoS One. 2017;12:e0182168.
PubMed Text format Abstract available

PELAEZ R, Morales X, Salvo E, Garasa S, et al
beta3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.
PLoS One. 2017;12:e0181579.
PubMed Text format Abstract available

MIRET M, Horvath-Puho E, Deruaz-Luyet A, Sorensen HT, et al
Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.
PLoS One. 2017;12:e0181564.
PubMed Text format Abstract available

TONG M, Wang J, Jiang N, Pan H, et al
Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
PLoS One. 2017;12:e0182282.
PubMed Text format Abstract available

SCHMIDT LH, Brand C, Stucke-Ring J, Schliemann C, et al
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
PLoS One. 2017;12:e0183201.
PubMed Text format Abstract available

CHEN B, Yang L, Zhang R, Gan Y, et al
Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients.
PLoS One. 2017;12:e0182891.
PubMed Text format Abstract available

CHENG CC, Chang J, Huang SC, Lin HC, et al
YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.
PLoS One. 2017;12:e0182149.
PubMed Text format Abstract available

NAKANO T, Kanai Y, Amano Y, Yoshimoto T, et al
Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures.
PLoS One. 2017;12:e0181342.
PubMed Text format Abstract available

PILYUGIN M, Descloux P, Andre PA, Laszlo V, et al
BARD1 serum autoantibodies for the detection of lung cancer.
PLoS One. 2017;12:e0182356.
PubMed Text format Abstract available

KIM EK, Kim KA, Lee CY, Shim HS, et al
The frequency and clinical impact of HER2 alterations in lung adenocarcinoma.
PLoS One. 2017;12:e0171280.
PubMed Text format Abstract available

WANICHTHANARAK K, Fan S, Grapov D, Barupal DK, et al
Metabox: A Toolbox for Metabolomic Data Analysis, Interpretation and Integrative Exploration.
PLoS One. 2017;12:e0171046.
PubMed Text format Abstract available

ORTIZ-ZAPATER E, Lee RW, Owen W, Weitsman G, et al
MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition.
PLoS One. 2017;12:e0170798.
PubMed Text format Abstract available

HARATI S, Cooper LA, Moran JD, Giuste FO, et al
MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.
PLoS One. 2017;12:e0170339.
PubMed Text format Abstract available

FANG Y, Zhang C, Wu T, Wang Q, et al
Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells.
PLoS One. 2017;12:e0170609.
PubMed Text format Abstract available

NIKOLOVSKA K, Spillmann D, Haier J, Ladanyi A, et al
Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase.
PLoS One. 2017;12:e0170054.
PubMed Text format Abstract available

KISELEVA R, Greineder CF, Villa CH, Hood ED, et al
Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1.
PLoS One. 2017;12:e0169537.
PubMed Text format Abstract available

ALSUBAIE N, Trahearn N, Raza SE, Snead D, et al
Stain Deconvolution Using Statistical Analysis of Multi-Resolution Stain Colour Representation.
PLoS One. 2017;12:e0169875.
PubMed Text format Abstract available

CHOUAID C, Debieuvre D, Durand-Zaleski I, Fernandes J, et al
Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).
PLoS One. 2017;12:e0182798.
PubMed Text format Abstract available

SHIN J, Song SY, Ahn HS, An BC, et al
Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS.
PLoS One. 2017;12:e0183896.
PubMed Text format Abstract available

JOVELET C, Madic J, Remon J, Honore A, et al
Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer.
PLoS One. 2017;12:e0183319.
PubMed Text format Abstract available

CHEN L, Lu J, Huang T, Cai YD, et al
A computational method for the identification of candidate drugs for non-small cell lung cancer.
PLoS One. 2017;12:e0183411.
PubMed Text format Abstract available

YANG JH, Li XY, Wang X, Hou WJ, et al
Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.
PLoS One. 2017;12:e0182775.
PubMed Text format Abstract available

KONG GM, Yu M, Gu Z, Chen Z, et al
Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity.
PLoS One. 2017;12:e0181601.
PubMed Text format Abstract available

ZHANG C, Wei B, Li P, Yang K, et al
Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs.
PLoS One. 2017;12:e0173524.
PubMed Text format Abstract available

WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
PLoS One. 2017;12:e0173933.
PubMed Text format Abstract available

ASOR E, Stav MY, Simon E, Fahoum I, et al
Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy.
PLoS One. 2017;12:e0173760.
PubMed Text format Abstract available

ECHTLER K, Konrad I, Lorenz M, Schneider S, et al
Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.
PLoS One. 2017;12:e0172788.
PubMed Text format Abstract available

PUNIA R, Raina K, Agarwal R, Singh RP, et al
Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells.
PLoS One. 2017;12:e0182870.
PubMed Text format Abstract available

VAN DER WEKKEN AJ, Kuiper JL, Saber A, Terpstra MM, et al
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression.
PLoS One. 2017;12:e0182885.
PubMed Text format Abstract available

HSU MK, Lin HY, Chen FC
NMD Classifier: A reliable and systematic classification tool for nonsense-mediated decay events.
PLoS One. 2017;12:e0174798.
PubMed Text format Abstract available

PARK JE, Chun SE, Reichel D, Min JS, et al
Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice.
PLoS One. 2017;12:e0173247.
PubMed Text format Abstract available

JIN J, Hu K, Zhou Y, Li W, et al
Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
PLoS One. 2017;12:e0184412.
PubMed Text format Abstract available

CAO X, MacNaughton P, Laurent JC, Allen JG, et al
Radon-induced lung cancer deaths may be overestimated due to failure to account for confounding by exposure to diesel engine exhaust in BEIR VI miner studies.
PLoS One. 2017;12:e0184298.
PubMed Text format Abstract available

DE BIASE D, Genestreti G, Visani M, Acquaviva G, et al
The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.
PLoS One. 2017;12:e0177822.
PubMed Text format Abstract available

HSIEH CC, Sun YH, Lin SW, Yeh YC, et al
Surgical outcomes of pulmonary mucoepidermoid carcinoma: A review of 41 cases.
PLoS One. 2017;12:e0176918.
PubMed Text format Abstract available

LEE DH, Hwang SH, Lim MK, Oh JK, et al
Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
PLoS One. 2017;12:e0176783.
PubMed Text format Abstract available

CAI G, Xiao F, Cheng C, Li Y, et al
Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients.
PLoS One. 2017;12:e0175850.
PubMed Text format Abstract available

AGRAWAL V, Coroller TP, Hou Y, Lee SW, et al
Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC.
PLoS One. 2017;12:e0174268.
PubMed Text format Abstract available

LYNCH CM, van Berkel VH, Frieboes HB
Application of unsupervised analysis techniques to lung cancer patient data.
PLoS One. 2017;12:e0184370.
PubMed Text format Abstract available

CAI NL, Lau ATY, Yu FY, Wu DD, et al
Purification and characterization of a highly specific polyclonal antibody against human extracellular signal-regulated kinase 8 and its detection in lung cancer.
PLoS One. 2017;12:e0184755.
PubMed Text format Abstract available

SHEN Z, Wang H, Xi W, Deng X, et al
Multi-phase simultaneous segmentation of tumor in lung 4D-CT data with context information.
PLoS One. 2017;12:e0178411.
PubMed Text format Abstract available

KOO HJ, Kim MY, Koo JH, Sung YS, et al
Computerized margin and texture analyses for differentiating bacterial pneumonia and invasive mucinous adenocarcinoma presenting as consolidation.
PLoS One. 2017;12:e0177379.
PubMed Text format Abstract available

ZHAO XK, Mao YM, Meng H, Song X, et al
Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China.
PLoS One. 2017;12:e0177504.
PubMed Text format Abstract available

FARQUHAR M, Penfold C, Benson J, Lovick R, et al
Six key topics informal carers of patients with breathlessness in advanced disease want to learn about and why: MRC phase I study to inform an educational intervention.
PLoS One. 2017;12:e0177081.
PubMed Text format Abstract available

WANG XF, Zhu YT, Wang JJ, Zeng DX, et al
The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients.
PLoS One. 2017;12:e0185168.
PubMed Text format Abstract available

ELLSWORTH SG, Rabatic BM, Chen J, Zhao J, et al
Principal component analysis identifies patterns of cytokine expression in non-small cell lung cancer patients undergoing definitive radiation therapy.
PLoS One. 2017;12:e0183239.
PubMed Text format Abstract available

WANG C, Zhang X, Li H, Li X, et al
Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
PLoS One. 2017;12:e0179664.
PubMed Text format Abstract available

WANG L, Tang C, Xu B, Yang L, et al
Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.
PLoS One. 2017;12:e0179000.
PubMed Text format Abstract available

YIP SSF, Parmar C, Blezek D, Estepar RSJ, et al
Application of the 3D slicer chest imaging platform segmentation algorithm for large lung nodule delineation.
PLoS One. 2017;12:e0178944.
PubMed Text format Abstract available

KEARNEY P, Hunsucker SW, Li XJ, Porter A, et al
An integrated risk predictor for pulmonary nodules.
PLoS One. 2017;12:e0177635.
PubMed Text format Abstract available

KEE JY, Han YH, Kim DS, Mun JG, et al
beta-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway.
PLoS One. 2017;12:e0176937.
PubMed Text format Abstract available

WANG T, Moon JY, Wu Y, Amos CI, et al
Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium.
PLoS One. 2017;12:e0185660.
PubMed Text format Abstract available

SHAN S, She J, Xue ZQ, Su CX, et al
Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies.
PLoS One. 2017;12:e0185485.
PubMed Text format Abstract available

WANG F, Xu X, Yang J, Min L, et al
Height and lung cancer risk: A meta-analysis of observational studies.
PLoS One. 2017;12:e0185316.
PubMed Text format Abstract available

CIRCU M, Cardelli J, Barr M, O'Byrne K, et al
Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
PLoS One. 2017;12:e0184922.
PubMed Text format Abstract available

NOWICKI-OSUCH K, Li Y, Challinor M, Gerrard DT, et al
EINCR1 is an EGF inducible lincRNA overexpressed in lung adenocarcinomas.
PLoS One. 2017;12:e0181902.
PubMed Text format Abstract available

PIRIE-SHEPHERD SR, Painter C, Whalen P, Vizcarra P, et al
Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients.
PLoS One. 2017;12:e0179561.
PubMed Text format Abstract available

TAKADA K, Okamoto T, Tominaga M, Teraishi K, et al
Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression.
PLoS One. 2017;12:e0181598.
PubMed Text format Abstract available

CHOI BH, Young HS, Quan YH, Rho J, et al
Real-time computed tomography fluoroscopy-guided solitary lung tumor model in a rabbit.
PLoS One. 2017;12:e0179220.
PubMed Text format Abstract available

LENDECKEL D, Kromrey ML, Ittermann T, Schafer S, et al
Pulmonary emphysema is a predictor of pneumothorax after CT-guided transthoracic pulmonary biopsies of pulmonary nodules.
PLoS One. 2017;12:e0178078.
PubMed Text format Abstract available

MINCHOM A, Thavasu P, Ahmad Z, Stewart A, et al
A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments.
PLoS One. 2017;12:e0186106.
PubMed Text format Abstract available

ILIE M, Khambata-Ford S, Copie-Bergman C, Huang L, et al
Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms.
PLoS One. 2017;12:e0183023.
PubMed Text format Abstract available

MUSCELLA A, Vetrugno C, Cossa LG, Antonaci G, et al
Apoptosis by [Pt(O,O'-acac)(gamma-acac)(DMS)] requires PKC-delta mediated p53 activation in malignant pleural mesothelioma.
PLoS One. 2017;12:e0181114.
PubMed Text format Abstract available

YVOREL V, Patoir A, Casteillo F, Tissot C, et al
PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
PLoS One. 2017;12:e0180346.
PubMed Text format Abstract available

BORIN TF, Shankar A, Angara K, Rashid MH, et al
HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model.
PLoS One. 2017;12:e0178830.
PubMed Text format Abstract available

KASPI E, Frankel D, Guinde J, Perrin S, et al
Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status.
PLoS One. 2017;12:e0183136.
PubMed Text format Abstract available

KROSNICK JA, Malhotra N, Mo CH, Bruera EF, et al
Perceptions of health risks of cigarette smoking: A new measure reveals widespread misunderstanding.
PLoS One. 2017;12:e0182063.
PubMed Text format Abstract available

TUDOR RA, D'Silva A, Tremblay A, MacEachern P, et al
Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients.
PLoS One. 2017;12:e0181867.
PubMed Text format Abstract available

JIN C, Zhang G, Zhang Y, Hua P, et al
Isoalantolactone induces intrinsic apoptosis through p53 signaling pathway in human lung squamous carcinoma cells.
PLoS One. 2017;12:e0181731.
PubMed Text format Abstract available

YU PY, Gardner HL, Roberts R, Cam H, et al
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
PLoS One. 2017;12:e0181885.
PubMed Text format Abstract available

NAKAMURA S, Hayashi K, Imaoka Y, Kitamura Y, et al
Intratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer.
PLoS One. 2017;12:e0186192.
PubMed Text format Abstract available

PEARCE A, Haas M, Viney R, Pearson SA, et al
Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
PLoS One. 2017;12:e0184360.
PubMed Text format Abstract available

D'HOOGHE JNS, Goorsenberg AWM, de Bruin DM, Roelofs JJTH, et al
Optical coherence tomography for identification and quantification of human airway wall layers.
PLoS One. 2017;12:e0184145.
PubMed Text format Abstract available

LIAO HF, Pan CH, Chou PY, Chen YF, et al
Toxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells.
PLoS One. 2017;12:e0185021.
PubMed Text format Abstract available

LAMBERT A, Jarlier M, Gourgou Bourgade S, Conroy T, et al
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
PLoS One. 2017;12:e0183288.
PubMed Text format Abstract available

SUTTON BC, Birse RT, Maggert K, Ray T, et al
Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX(R) HS, a new highly sensitive assay for the MassARRAY(R) System.
PLoS One. 2017;12:e0183715.
PubMed Text format Abstract available

BUONOMO OC, Caredda E, Portarena I, Vanni G, et al
New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
PLoS One. 2017;12:e0184680.
PubMed Text format Abstract available

HUANG JY, Wang R, Gao YT, Yuan JM, et al
ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
PLoS One. 2017;12:e0184295.
PubMed Text format Abstract available

KWIECIEN JM, Bassey-Archibong BI, Dabrowski W, Rayner LG, et al
Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis.
PLoS One. 2017;12:e0183883.
PubMed Text format Abstract available

FORNARO L, Vivaldi C, Lin D, Xue H, et al
Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.
PLoS One. 2017;12:e0182818.
PubMed Text format Abstract available

LI Y, Xu H, Su S, Ye J, et al
Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.
PLoS One. 2017;12:e0183331.
PubMed Text format Abstract available

KWAK KM, Paek D, Hwang SS, Ju YS, et al
Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033.
PLoS One. 2017;12:e0183404.
PubMed Text format Abstract available

NOGUEIRA JORGE NA, Wajnberg G, Ferreira CG, de Sa Carvalho B, et al
snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma.
PLoS One. 2017;12:e0183410.
PubMed Text format Abstract available

VANDEREYKEN M, Jacques S, Van Overmeire E, Amand M, et al
Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner.
PLoS One. 2017;12:e0185786.
PubMed Text format Abstract available

MOON MH, Beck KS, Moon YK, Park JK, et al
Incidence and clinical features of the incidentally found vascular stump thrombus during routine follow up after oncologic lung surgery.
PLoS One. 2017;12:e0185140.
PubMed Text format Abstract available

JIANG R, Dong X, Zhu W, Duan Q, et al
Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers.
PLoS One. 2017;12:e0184338.
PubMed Text format Abstract available

KIND M, Klukowska-Rotzler J, Berezowska S, Arcaro A, et al
Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis.
PLoS One. 2017;12:e0187308.
PubMed Text format Abstract available

FORCELLA M, Oldani M, Epistolio S, Freguia S, et al
Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3.
PLoS One. 2017;12:e0187289.
PubMed Text format Abstract available

SCHMIDT LH, Heitkotter B, Schulze AB, Schliemann C, et al
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer.
PLoS One. 2017;12:e0186280.
PubMed Text format Abstract available

OTOSHI T, Kataoka Y, Ikegaki S, Saito E, et al
Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center.
PLoS One. 2017;12:e0185850.
PubMed Text format Abstract available

ZHAO J, Dinkel J, Warth A, Penzel R, et al
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation.
PLoS One. 2017;12:e0182741.
PubMed Text format Abstract available

LIU K, Zheng D, Xu G, Du Z, et al
Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis.
PLoS One. 2017;12:e0187350.
PubMed Text format Abstract available

ARNS A, Blessing M, Fleckenstein J, Stsepankou D, et al
Phantom-based evaluation of dose exposure of ultrafast combined kV-MV-CBCT towards clinical implementation for IGRT of lung cancer.
PLoS One. 2017;12:e0187710.
PubMed Text format Abstract available

CHEN YF, Yuan A, Cho KH, Lu YC, et al
Functional evaluation of therapeutic response of HCC827 lung cancer to bevacizumab and erlotinib targeted therapy using dynamic contrast-enhanced and diffusion-weighted MRI.
PLoS One. 2017;12:e0187824.
PubMed Text format Abstract available

JABS V, Edlund K, Konig H, Grinberg M, et al
Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer.
PLoS One. 2017;12:e0187246.
PubMed Text format Abstract available

FRENZEL T, Hoffmann B, Schmitz R, Bethge A, et al
Radiotherapy and chemotherapy change vessel tree geometry and metastatic spread in a small cell lung cancer xenograft mouse tumor model.
PLoS One. 2017;12:e0187144.
PubMed Text format Abstract available

SEO SR, Lee HM, Choi HS, Kim WT, et al
Enhanced expression of cell-surface B-cell receptor-associated protein 31 contributes to poor survival of non-small cell lung carcinoma cells.
PLoS One. 2017;12:e0188075.
PubMed Text format Abstract available

SIKDAR S, Datta S, Datta S
EAMA: Empirically adjusted meta-analysis for large-scale simultaneous hypothesis testing in genomic experiments.
PLoS One. 2017;12:e0187287.
PubMed Text format Abstract available

LIN CY, Wu YM, Hsieh MH, Wang CW, et al
Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma.
PLoS One. 2017;12:e0186567.
PubMed Text format Abstract available

JIAO DM, Yan L, Wang LS, Hu HZ, et al
Retraction: Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
PLoS One. 2017;12:e0189070.
PubMed Text format

LIU B, Zhao Y, Yuan J, Zeng L, et al
Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis.
PLoS One. 2017;12:e0187860.
PubMed Text format Abstract available

VAN RIEL SJ, Ciompi F, Winkler Wille MM, Dirksen A, et al
Malignancy risk estimation of pulmonary nodules in screening CTs: Comparison between a computer model and human observers.
PLoS One. 2017;12:e0185032.
PubMed Text format Abstract available

LI R, Zhang Y, Yuan Y, Lin Q, et al
Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.
PLoS One. 2017;12:e0187390.
PubMed Text format Abstract available

ZHOU S, Wang P, Su X, Chen J, et al
High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
PLoS One. 2017;12:e0187356.
PubMed Text format Abstract available

MARCOS-VADILLO E, Garcia-Sanchez A, Sanz C, Davila I, et al
PTGDR gene expression and response to dexamethasone treatment in an in vitro model.
PLoS One. 2017;12:e0186957.
PubMed Text format Abstract available

ISAKSSON S, Jonsson P, Monsef N, Brunnstrom H, et al
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma.
PLoS One. 2017;12:e0186284.
PubMed Text format Abstract available

BRINKHOF S, Groen HJM, Siesling SS, IJzerman MJ, et al
Resource utilization in lung cancer diagnostic procedures: Current use and budget consequences.
PLoS One. 2017;12:e0189251.
PubMed Text format Abstract available

KIM ES, Baran AM, Mondo EL, Rodgers TD, et al
Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
PLoS One. 2017;12:e0189410.
PubMed Text format Abstract available

ZHANG H, Diao H, Jia L, Yuan Y, et al
Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
PLoS One. 2017;12:e0188960.
PubMed Text format Abstract available

OOI CC, Mantalas GL, Koh W, Neff NF, et al
High-throughput full-length single-cell mRNA-seq of rare cells.
PLoS One. 2017;12:e0188510.
PubMed Text format Abstract available

KANG G, Liu K, Hou B, Zhang N, et al
3D multi-view convolutional neural networks for lung nodule classification.
PLoS One. 2017;12:e0188290.
PubMed Text format Abstract available

HAN KN, Kim HK, Choi YH
Midterm outcomes of single port thoracoscopic surgery for major pulmonary resection.
PLoS One. 2017;12:e0186857.
PubMed Text format Abstract available

KIM H, Park CM, Keam B, Park SJ, et al
The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.
PLoS One. 2017;12:e0187500.
PubMed Text format Abstract available

GALLARDO-ESTRELLA L, Pompe E, de Jong PA, Jacobs C, et al
Normalized emphysema scores on low dose CT: Validation as an imaging biomarker for mortality.
PLoS One. 2017;12:e0188902.
PubMed Text format Abstract available

TAKAHASHI Y, Yasui T, Tamari K, Minami K, et al
Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.
PLoS One. 2017;12:e0189697.
PubMed Text format Abstract available

SABIR SH, Krishnamurthy S, Gupta S, Mills GB, et al
Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing.
PLoS One. 2017;12:e0189651.
PubMed Text format Abstract available

January 2016

LOHINAI Z, Dome P, Szilagyi Z, Ostoros G, et al
From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC).
PLoS One. 2016;11:e0144797.
PubMed Text format Abstract available

GUERRERA F, Tabbo F, Bessone L, Maletta F, et al
The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.
PLoS One. 2016;11:e0145100.
PubMed Text format Abstract available

LIU J, Dong M, Sun X, Li W, et al
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
PLoS One. 2016;11:e0146195.
PubMed Text format Abstract available

HAGEDOORN P, Vandenheede H, Willaert D, Vanthomme K, et al
Regional Inequalities in Lung Cancer Mortality in Belgium at the Beginning of the 21st Century: The Contribution of Individual and Area-Level Socioeconomic Status and Industrial Exposure.
PLoS One. 2016;11:e0147099.
PubMed Text format Abstract available

YANG Y, Nguyen TT, Jeong MH, Crisan F, et al
Inhibitory Activity of (+)-Usnic Acid against Non-Small Cell Lung Cancer Cell Motility.
PLoS One. 2016;11:e0146575.
PubMed Text format Abstract available

YOSHIDA T, Song L, Bai Y, Kinose F, et al
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0147344.
PubMed Text format Abstract available

QIU ZX, Sun RF, Mo XM, Li WM, et al
The p70S6K Specific Inhibitor PF-4708671 Impedes Non-Small Cell Lung Cancer Growth.
PLoS One. 2016;11:e0147185.
PubMed Text format Abstract available

MEREDITH SL, Bryant JL, Babur M, Riddell PW, et al
Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo.
PLoS One. 2016;11:e0148404.
PubMed Text format Abstract available

HU M, Hu Y, He J, Li B, et al
Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.
PLoS One. 2016;11:e0147374.
PubMed Text format Abstract available

LI W, Wang Y, Zhang Q, Tang L, et al
Correction: MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0148589.
PubMed Text format Abstract available

AVILA-MORENO F, Armas-Lopez L, Alvarez-Moran AM, Lopez-Bujanda Z, et al
Correction: Overexpression of MEOX2 and TWIST1 is Associated with H3K27me3 Levels and Determines Lung Cancer Chemoresistance and Prognosis.
PLoS One. 2016;11:e0146569.
PubMed Text format Abstract available

MALANGA D, Belmonte S, Colelli F, Scarfo M, et al
AKT1E17K Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer.
PLoS One. 2016;11:e0147334.
PubMed Text format Abstract available

LUI NS, Yang YW, van Zante A, Buchanan P, et al
SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.
PLoS One. 2016;11:e0148911.
PubMed Text format Abstract available

KHAN S, Imran A, Khan AA, Abul Kalam M, et al
Systems Biology Approaches for the Prediction of Possible Role of Chlamydia pneumoniae Proteins in the Etiology of Lung Cancer.
PLoS One. 2016;11:e0148530.
PubMed Text format Abstract available

CHEN YM, Lai CH, Chang HC, Chao TY, et al
Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
PLoS One. 2016;11:e0149722.
PubMed Text format Abstract available

CHANG WH, Ho BC, Hsiao YJ, Chen JS, et al
JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer.
PLoS One. 2016;11:e0150355.
PubMed Text format Abstract available

CHENG NM, Fang YH, Tsan DL, Hsu CH, et al
Respiration-Averaged CT for Attenuation Correction of PET Images - Impact on PET Texture Features in Non-Small Cell Lung Cancer Patients.
PLoS One. 2016;11:e0150509.
PubMed Text format Abstract available

SHERWOOD JL, Corcoran C, Brown H, Sharpe AD, et al
Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC).
PLoS One. 2016;11:e0150197.
PubMed Text format Abstract available

BAYARRI-LARA C, Ortega FG, Cueto Ladron de Guevara A, Puche JL, et al
Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
PLoS One. 2016;11:e0148659.
PubMed Text format Abstract available

HOWE GA, Xiao B, Zhao H, Al-Zahrani KN, et al
Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0150567.
PubMed Text format Abstract available

REGAN E, Sibley RC, Cenik BK, Silva A, et al
Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines.
PLoS One. 2016;11:e0150963.
PubMed Text format Abstract available

BAI XY, Zhang XC, Yang SQ, An SJ, et al
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.
PLoS One. 2016;11:e0149370.
PubMed Text format Abstract available

ZHANG Y, Jiang M, Li Q, Liang W, et al
Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.
PLoS One. 2016;11:e0149946.
PubMed Text format Abstract available

LEUNG AW, Hung SS, Backstrom I, Ricaurte D, et al
Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In Vitro.
PLoS One. 2016;11:e0150675.
PubMed Text format Abstract available

SAITO K, Nakayama E, Valmori D
Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
PLoS One. 2016;11:e0150623.
PubMed Text format Abstract available

LI R, Pu X, Chang JY, Ye Y, et al
MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0150467.
PubMed Text format Abstract available

DEDONG C, Huilin X, Anbing H, Ximing X, et al
The Effect of ShenQi FuZheng Injection in Combination with Chemotherapy versus Chemotherapy Alone on the Improvement of Efficacy and Immune Function in Patients with Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.
PLoS One. 2016;11:e0152270.
PubMed Text format Abstract available

ZHANG C, Zhang H, Shi J, Wang D, et al
Trial-Based Cost-Utility Analysis of Icotinib versus Gefitinib as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer in China.
PLoS One. 2016;11:e0151846.
PubMed Text format Abstract available

ZHANG Q, Gao M, Luo G, Han X, et al
Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the beta-Catenin/Tcf4 Interaction.
PLoS One. 2016;11:e0152407.
PubMed Text format Abstract available

SABER A, van der Wekken AJ, Kerner GS, van den Berge M, et al
Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0152317.
PubMed Text format Abstract available

ZHOU YY, Hu ZG, Zeng FJ, Han J, et al
Clinical Profile of Cyclooxygenase-2 Inhibitors in Treating Non-Small Cell Lung Cancer: A Meta-Analysis of Nine Randomized Clinical Trials.
PLoS One. 2016;11:e0151939.
PubMed Text format Abstract available

DE GREVE J, Van Meerbeeck J, Vansteenkiste JF, Decoster L, et al
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
PLoS One. 2016;11:e0147599.
PubMed Text format Abstract available

LYONS JD, Mittal R, Fay KT, Chen CW, et al
Murine Lung Cancer Increases CD4+ T Cell Apoptosis and Decreases Gut Proliferative Capacity in Sepsis.
PLoS One. 2016;11:e0149069.
PubMed Text format Abstract available

CARDNELL RJ, Feng Y, Mukherjee S, Diao L, et al
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.
PLoS One. 2016;11:e0152584.
PubMed Text format Abstract available

PARK SA, Lee JW, Herbst RS, Koo JS, et al
GSK-3alpha Is a Novel Target of CREB and CREB-GSK-3alpha Signaling Participates in Cell Viability in Lung Cancer.
PLoS One. 2016;11:e0153075.
PubMed Text format Abstract available

RAES F, Sobilo J, Le Mee M, Retif S, et al
High Resolution Ultrasound and Photoacoustic Imaging of Orthotopic Lung Cancer in Mice: New Perspectives for Onco-Pharmacology.
PLoS One. 2016;11:e0153532.
PubMed Text format Abstract available

MIYAZAKI R, Anayama T, Hirohashi K, Okada H, et al
In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer.
PLoS One. 2016;11:e0152665.
PubMed Text format Abstract available

ZHU W, Zhou K, Zha Y, Chen D, et al
Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0153046.
PubMed Text format Abstract available

O SANTOS A, Parrini MC, Camonis J
RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases.
PLoS One. 2016;11:e0154840.
PubMed Text format Abstract available

KERNER GS, Koole MJ, Bongaerts AH, Pruim J, et al
Total Body Metabolic Tumor Response in ALK Positive Non-Small Cell Lung Cancer Patients Treated with ALK Inhibition.
PLoS One. 2016;11:e0149955.
PubMed Text format Abstract available

SUTIMAN N, Zhang Z, Tan EH, Ang MK, et al
Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules.
PLoS One. 2016;11:e0154316.
PubMed Text format Abstract available

TSENG CY, Lin CH, Wu LY, Wang JS, et al
Potential Combinational Anti-Cancer Therapy in Non-Small Cell Lung Cancer with Traditional Chinese Medicine Sun-Bai-Pi Extract and Cisplatin.
PLoS One. 2016;11:e0155469.
PubMed Text format Abstract available

JIN KN, Sung YW, Oh SJ, Choi YR, et al
Association between Image Characteristics on Chest CT and Severe Pleural Adhesion during Lung Cancer Surgery.
PLoS One. 2016;11:e0154694.
PubMed Text format Abstract available

GAO C, Shen Y, Jin F, Miao Y, et al
Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
PLoS One. 2016;11:e0154576.
PubMed Text format Abstract available

CARDONA AF, Rojas L, Wills B, Arrieta O, et al
Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression.
PLoS One. 2016;11:e0154293.
PubMed Text format Abstract available

BODNAR M, Guerrero P, Perez-Carrasco R, Piotrowska MJ, et al
Deterministic and Stochastic Study for a Microscopic Angiogenesis Model: Applications to the Lewis Lung Carcinoma.
PLoS One. 2016;11:e0155553.
PubMed Text format Abstract available

LIU XQ, Kiefl R, Roskopf C, Tian F, et al
Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression.
PLoS One. 2016;11:e0156268.
PubMed Text format Abstract available

ZHU L, Zhang S, Xu X, Wang B, et al
Increased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review.
PLoS One. 2016;11:e0156494.
PubMed Text format Abstract available

SALTYBAEVA N, Martini K, Frauenfelder T, Alkadhi H, et al
Organ Dose and Attributable Cancer Risk in Lung Cancer Screening with Low-Dose Computed Tomography.
PLoS One. 2016;11:e0155722.
PubMed Text format Abstract available

PATEL YM, Park SL, Carmella SG, Paiano V, et al
Metabolites of the Polycyclic Aromatic Hydrocarbon Phenanthrene in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.
PLoS One. 2016;11:e0156203.
PubMed Text format Abstract available

ZHAO J, Xia Y, Kaminski J, Hao Z, et al
Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies.
PLoS One. 2016;11:e0157455.
PubMed Text format Abstract available

ENEWOLD L, Thomas A
Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States.
PLoS One. 2016;11:e0156728.
PubMed Text format Abstract available

WEI Y, Zhao W, Huang Y, Yu Q, et al
A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
PLoS One. 2016;11:e0157606.
PubMed Text format Abstract available

DONG X, Sun X, Sun L, Maxim PG, et al
Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0157836.
PubMed Text format Abstract available

GROTTKE A, Ewald F, Lange T, Norz D, et al
Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
PLoS One. 2016;11:e0146370.
PubMed Text format Abstract available

HUANG Q, Wei H, Wu Z, Li L, et al
Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis.
PLoS One. 2016;11:e0149640.
PubMed Text format Abstract available

LU YC, Lee YR, Liao JD, Lin CY, et al
Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells.
PLoS One. 2016;11:e0158587.
PubMed Text format Abstract available

HUNG MS, Chen IC, Lung JH, Lin PY, et al
Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells.
PLoS One. 2016;11:e0158395.
PubMed Text format Abstract available

LI D, Shi J, Du Y, Chen K, et al
Profiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF Treatment.
PLoS One. 2016;11:e0158214.
PubMed Text format Abstract available

RAO Q, You A, Guo Z, Zuo B, et al
Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models.
PLoS One. 2016;11:e0148263.
PubMed Text format Abstract available

ANDO K, Okada Y, Akiba M, Kondo T, et al
Lung Transplantation for Lymphangioleiomyomatosis in Japan.
PLoS One. 2016;11:e0146749.
PubMed Text format Abstract available

KOO HJ, Lee M, Kim J, Woo CW, et al
Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.
PLoS One. 2016;11:e0148784.
PubMed Text format Abstract available

KIM H, Park CM, Song YS, Sunwoo L, et al
Measurement Variability of Persistent Pulmonary Subsolid Nodules on Same-Day Repeat CT: What Is the Threshold to Determine True Nodule Growth during Follow-Up?
PLoS One. 2016;11:e0148853.
PubMed Text format Abstract available

KICIELINSKA J, Szczygiel A, Rossowska J, Anger N, et al
Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models.
PLoS One. 2016;11:e0148156.
PubMed Text format Abstract available

PAPADODIMA O, Moulos P, Koryllou A, Piroti G, et al
Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.
PLoS One. 2016;11:e0160248.
PubMed Text format

IM JS, Herrmann AC, Bernatchez C, Haymaker C, et al
Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer.
PLoS One. 2016;11:e0160004.
PubMed Text format Abstract available

SARDARO A, Saito K, Nakayama E, Valmori D, et al
Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
PLoS One. 2016;11:e0160538.
PubMed Text format Abstract available

LIU M, Feng LX, Sun P, Liu W, et al
A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice.
PLoS One. 2016;11:e0159789.
PubMed Text format Abstract available

Retraction: Association of CYP2A6*4 with Susceptibility of Lung Cancer: A Meta-Analysis.
PLoS One. 2016;11:e0160299.
PubMed Text format

WANG CM, Ling ZG, Wu YB, Cai SQ, et al
Prognostic Value of Pleural Lavage Cytology in Patients with Lung Cancer Resection: An Updated Meta-Analysis.
PLoS One. 2016;11:e0157518.
PubMed Text format Abstract available

JIAN ZH, Huang JY, Lin FC, Nfor ON, et al
Post-Inhaled Corticosteroid Pulmonary Tuberculosis Increases Lung Cancer in Patients with Asthma.
PLoS One. 2016;11:e0159683.
PubMed Text format Abstract available

LI P, Zhang G, Li J, Yang R, et al
Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma.
PLoS One. 2016;11:e0150790.
PubMed Text format Abstract available

LI W, Pi X, Qiao P, Liu H, et al
Collecting Protein Biomarkers in Breath Using Electret Filters: A Preliminary Method on New Technical Model and Human Study.
PLoS One. 2016;11:e0150481.
PubMed Text format Abstract available

CADIER B, Durand-Zaleski I, Thomas D, Chevreul K, et al
Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.
PLoS One. 2016;11:e0148750.
PubMed Text format Abstract available

ROONEY C, Geh C, Williams V, Heuckmann JM, et al
Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.
PLoS One. 2016;11:e0149628.
PubMed Text format Abstract available

HUANG T, Li J, Zhang C, Hong Q, et al
Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis.
PLoS One. 2016;11:e0149088.
PubMed Text format Abstract available

YUAN P, Cao JL, Abuduwufuer A, Wang LM, et al
Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
PLoS One. 2016;11:e0146803.
PubMed Text format Abstract available

LIM EA, Lee H, Bae E, Lim J, et al
Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea.
PLoS One. 2016;11:e0160155.
PubMed Text format Abstract available

HU X, Pu K, Feng X, Wen S, et al
Role of Gemcitabine and Pemetrexed as Maintenance Therapy in Advanced NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PLoS One. 2016;11:e0149247.
PubMed Text format Abstract available

WENG TY, Wang CY, Hung YH, Chen WC, et al
Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.
PLoS One. 2016;11:e0161007.
PubMed Text format Abstract available

KUMAR A, Corey C, Scott I, Shiva S, et al
Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0160783.
PubMed Text format Abstract available

LI K, Yu Y, Sun S, Liu Y, et al
Functional Characterisation of Anticancer Activity in the Aqueous Extract of Helicteres angustifolia L. Roots.
PLoS One. 2016;11:e0152017.
PubMed Text format Abstract available

FURUYA M, Tanaka R, Okudela K, Nakamura S, et al
Pulmonary Neoplasms in Patients with Birt-Hogg-Dube Syndrome: Histopathological Features and Genetic and Somatic Events.
PLoS One. 2016;11:e0151476.
PubMed Text format Abstract available

SHENG J, Yang YP, Ma YX, Qin T, et al
Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.
PLoS One. 2016;11:e0147226.
PubMed Text format Abstract available

LI BT, Lou E, Hsu M, Yu HA, et al
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
PLoS One. 2016;11:e0146063.
PubMed Text format Abstract available

DIETZ S, Schirmer U, Merce C, von Bubnoff N, et al
Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients.
PLoS One. 2016;11:e0161012.
PubMed Text format Abstract available

ZHANG W, Ning N, Li X, Niu G, et al
Changes of Brain Glucose Metabolism in the Pretreatment Patients with Non-Small Cell Lung Cancer: A Retrospective PET/CT Study.
PLoS One. 2016;11:e0161325.
PubMed Text format Abstract available

BEN AMOR A, Beauchemin K, Faucher MC, Hamzaoui A, et al
Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
PLoS One. 2016;11:e0161210.
PubMed Text format Abstract available

REIGSTAD I, Smeland HY, Skogstrand T, Sortland K, et al
Stromal Integrin alpha11beta1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently.
PLoS One. 2016;11:e0151663.
PubMed Text format Abstract available

ARENS AI, Postema JW, Schreurs WM, Lafeber A, et al
FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.
PLoS One. 2016;11:e0160539.
PubMed Text format Abstract available

O'DOWD EL, McKeever TM, Baldwin DR, Hubbard RB, et al
Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013.
PLoS One. 2016;11:e0161399.
PubMed Text format Abstract available

KIM EY, Kim YS, Seo JY, Park I, et al
The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer.
PLoS One. 2016;11:e0161125.
PubMed Text format Abstract available

SALAMEKH S, Rong Y, Ayan AS, Mo X, et al
Inter-Fraction Tumor Volume Response during Lung Stereotactic Body Radiation Therapy Correlated to Patient Variables.
PLoS One. 2016;11:e0153245.
PubMed Text format Abstract available

KIKUTAKE C, Yahara K
Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis.
PLoS One. 2016;11:e0152918.
PubMed Text format Abstract available

GHAGHADA KB, Sato AF, Starosolski ZA, Berg J, et al
Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer.
PLoS One. 2016;11:e0152718.
PubMed Text format Abstract available

PATEL P, Kato T, Ujiie H, Wada H, et al
Multi-Modal Imaging in a Mouse Model of Orthotopic Lung Cancer.
PLoS One. 2016;11:e0161991.
PubMed Text format Abstract available

HU X, He W, Wen S, Feng X, et al
Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis.
PLoS One. 2016;11:e0151988.
PubMed Text format Abstract available

CASTRO NP, Merchant AS, Saylor KL, Anver MR, et al
Adaptation of Laser Microdissection Technique for the Study of a Spontaneous Metastatic Mammary Carcinoma Mouse Model by NanoString Technologies.
PLoS One. 2016;11:e0153270.
PubMed Text format Abstract available

LIEW KL, Jee JM, Yap I, Yong PV, et al
In Vitro Analysis of Metabolites Secreted during Infection of Lung Epithelial Cells by Cryptococcus neoformans.
PLoS One. 2016;11:e0153356.
PubMed Text format Abstract available

SABER A, van der Wekken AJ, Kok K, Terpstra MM, et al
Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing.
PLoS One. 2016;11:e0153065.
PubMed Text format Abstract available

KASAI S, Arakawa N, Okubo A, Shigeeda W, et al
NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG.
PLoS One. 2016;11:e0153181.
PubMed Text format Abstract available

GRECKA E, Statkiewicz M, Gorska A, Biernacka M, et al
Prenyl Ammonium Salts - New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.
PLoS One. 2016;11:e0153633.
PubMed Text format Abstract available

SEHGAL IS, Dhooria S, Gupta N, Bal A, et al
Impact of Endobronchial Ultrasound (EBUS) Training on the Diagnostic Yield of Conventional Transbronchial Needle Aspiration for Lymph Node Stations 4R and 7.
PLoS One. 2016;11:e0153793.
PubMed Text format Abstract available

NORONHA V, Ramaswamy A, Patil VM, Joshi A, et al
ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country.
PLoS One. 2016;11:e0160752.
PubMed Text format Abstract available

FENG Y, Zhou J, Li Z, Jiang Y, et al
Small Molecular TRAIL Inducer ONC201 Induces Death in Lung Cancer Cells: A Preclinical Study.
PLoS One. 2016;11:e0162133.
PubMed Text format Abstract available

KOO HJ, Do KH, Lee JB, Alblushi S, et al
Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review and Meta-Analysis.
PLoS One. 2016;11:e0161437.
PubMed Text format Abstract available

ZENG Y, Ruan W, He J, Zhang J, et al
Adoptive Immunotherapy in Postoperative Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
PLoS One. 2016;11:e0162630.
PubMed Text format Abstract available

FLECKENSTEIN J, Jelden M, Kremp S, Jagoda P, et al
The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer.
PLoS One. 2016;11:e0162816.
PubMed Text format Abstract available

LEE H, Kim Y, Jeong JH, Ryu JH, et al
ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene.
PLoS One. 2016;11:e0162335.
PubMed Text format Abstract available

CHI A, Wen S, Monga M, Almubarak M, et al
Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0162453.
PubMed Text format Abstract available

YAN F, Pang J, Peng Y, Molina JR, et al
Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells.
PLoS One. 2016;11:e0162925.
PubMed Text format Abstract available

TRAN TB, Baek C, Min J
Electric Cell-Substrate Impedance Sensing (ECIS) with Microelectrode Arrays for Investigation of Cancer Cell-Fibroblasts Interaction.
PLoS One. 2016;11:e0153813.
PubMed Text format Abstract available

KANG HJ, Hwangbo B, Lee JS, Kim MS, et al
Comparison of Epidermal Growth Factor Receptor Mutations between Metastatic Lymph Node Diagnosed by EBUS-TBNA and Primary Tumor in Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0163652.
PubMed Text format Abstract available

LI H, Ren Y, Xia L, Qu R, et al
Association of MicroRNA-149 Polymorphism with Lung Cancer Risk in Chinese Non-Smoking Female: A Case-Control Study.
PLoS One. 2016;11:e0163626.
PubMed Text format Abstract available

KIM EY, Kim N, Kim YS, Seo JY, et al
Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
PLoS One. 2016;11:e0164056.
PubMed Text format Abstract available

WANG J, Kalhor N, Hu J, Wang B, et al
Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.
PLoS One. 2016;11:e0163397.
PubMed Text format Abstract available

FUJITA H, Gomori A, Fujioka Y, Kataoka Y, et al
High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.
PLoS One. 2016;11:e0164830.
PubMed Text format Abstract available

WANG Z, Hu Y, Wang Y, Han W, et al
Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-Analysis.
PLoS One. 2016;11:e0164416.
PubMed Text format Abstract available

LYCAN TW, Pardee TS, Petty WJ, Bonomi M, et al
A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.
PLoS One. 2016;11:e0164244.
PubMed Text format Abstract available

LIN J, Zhang Y, Wang H, Chang J, et al
Genetic Polymorphisms in the Apoptosis-Associated Gene CASP3 and the Risk of Lung Cancer in Chinese Population.
PLoS One. 2016;11:e0164358.
PubMed Text format Abstract available

ZAPOROZHCHENKO IA, Morozkin ES, Skvortsova TE, Ponomaryova AA, et al
Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer.
PLoS One. 2016;11:e0165261.
PubMed Text format Abstract available

KORRODI-GREGORIO L, Soto-Cerrato V, Vitorino R, Fardilha M, et al
From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research.
PLoS One. 2016;11:e0165973.
PubMed Text format Abstract available

WAGLAND R, Brindle L, Ewings S, James E, et al
Promoting Help-Seeking in Response to Symptoms amongst Primary Care Patients at High Risk of Lung Cancer: A Mixed Method Study.
PLoS One. 2016;11:e0165677.
PubMed Text format Abstract available

KINSEY CM, Hamlington KL, O'Toole J, Stapleton R, et al
Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population.
PLoS One. 2016;11:e0165471.
PubMed Text format Abstract available

WALTER RF, Werner R, Vollbrecht C, Hager T, et al
ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology.
PLoS One. 2016;11:e0165181.
PubMed Text format Abstract available

KRUER TL, Dougherty SM, Reynolds L, Long E, et al
Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
PLoS One. 2016;11:e0166363.
PubMed Text format Abstract available

KUNISAWA S, Fushimi K, Imanaka Y
Reducing Length of Hospital Stay Does Not Increase Readmission Rates in Early-Stage Gastric, Colon, and Lung Cancer Surgical Cases in Japanese Acute Care Hospitals.
PLoS One. 2016;11:e0166269.
PubMed Text format Abstract available

MIYAZAKI R, Anayama T, Hirohashi K, Okada H, et al
Correction: In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer.
PLoS One. 2016;11:e0166505.
PubMed Text format Abstract available

WANG BY, Huang JY, Hung WH, Lin CH, et al
Impact on Survival on Interval between Surgery and Adjuvant Chemotherapy in Completely Resected Stage IB-IIIA Lung Cancer.
PLoS One. 2016;11:e0163809.
PubMed Text format Abstract available

MENG Q, Ren M, Li Y, Song X, et al
LncRNA-RMRP Acts as an Oncogene in Lung Cancer.
PLoS One. 2016;11:e0164845.
PubMed Text format Abstract available

Correction: ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country.
PLoS One. 2016;11:e0168221.
PubMed Text format Abstract available

CHEN YM, Fang YT, Lai CH, Rau KM, et al
A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases.
PLoS One. 2016;11:e0167923.
PubMed Text format Abstract available

HELLWIG B, Madjar K, Edlund K, Marchan R, et al
Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy.
PLoS One. 2016;11:e0167585.
PubMed Text format Abstract available

PRICE DN, McBride AA, Anton M, Kusewitt DF, et al
Longitudinal Assessment of Lung Cancer Progression in Mice Using the Sodium Iodide Symporter Reporter Gene and SPECT/CT Imaging.
PLoS One. 2016;11:e0169107.
PubMed Text format Abstract available

SUN L, Liu X, Fu H, Zhou W, et al
2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells.
PLoS One. 2016;11:e0168793.
PubMed Text format Abstract available

FUJIMOTO D, Kato R, Morimoto T, Shimizu R, et al
Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung Cancer.
PLoS One. 2016;11:e0168465.
PubMed Text format Abstract available

LAI X, Friedman A
Exosomal miRs in Lung Cancer: A Mathematical Model.
PLoS One. 2016;11:e0167706.
PubMed Text format Abstract available

WEI WE, Mao NQ, Ning SF, Li JL, et al
An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, China.
PLoS One. 2016;11:e0168795.
PubMed Text format Abstract available

AMERATUNGA M, Asadi K, Lin X, Walkiewicz M, et al
PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.
PLoS One. 2016;11:e0153954.
PubMed Text format Abstract available

GOK DURNALI A, Paksoy Turkoz F, Ardic Yukruk F, Tokluoglu S, et al
Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups.
PLoS One. 2016;11:e0152621.
PubMed Text format Abstract available

ZHANG L, Qian H, Sha M, Luan Z, et al
Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression.
PLoS One. 2016;11:e0164838.
PubMed Text format Abstract available

FORGACS A, Pall Jonsson H, Dahlbom M, Daver F, et al
A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images.
PLoS One. 2016;11:e0164113.
PubMed Text format Abstract available

ZHANG L, Wang L, Tian P, Tian S, et al
Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method.
PLoS One. 2016;11:e0165543.
PubMed Text format Abstract available

APRELIKOVA O, Tomlinson CC, Hoenerhoff M, Hixon JA, et al
Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
PLoS One. 2016;11:e0155262.
PubMed Text format Abstract available

SCHUSTER C, Akslen LA, Straume O
Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
PLoS One. 2016;11:e0155242.
PubMed Text format Abstract available

SLADE RL, Pisaneschi F, Nguyen QD, Smith G, et al
Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography.
PLoS One. 2016;11:e0161427.
PubMed Text format Abstract available

WANG D, Zhang M, Gao X, Yu L, et al
Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
PLoS One. 2016;11:e0158307.
PubMed Text format Abstract available

January 2015

MORENO P, Lara-Chica M, Soler-Torronteras R, Caro T, et al
The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
PLoS One. 2015;10:e0143376.
PubMed Text format Abstract available

GOZZARD P, Chapman C, Vincent A, Lang B, et al
Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
PLoS One. 2015;10:e0143558.
PubMed Text format Abstract available

HU X, Zhang L, Shi Y, Zhou C, et al
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
PLoS One. 2015;10:e0142500.
PubMed Text format Abstract available

SHI Y, Li J, Zhang S, Wang M, et al
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study.
PLoS One. 2015;10:e0143515.
PubMed Text format Abstract available

WEN SW, Everitt SJ, Bedo J, Chabrot M, et al
Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy.
PLoS One. 2015;10:e0142608.
PubMed Text format Abstract available

ZHAN W, Han T, Zhang C, Xie C, et al
TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.
PLoS One. 2015;10:e0142596.
PubMed Text format Abstract available

MING X, Feng Y, Liu H, Zhang Y, et al
Cardiac Exposure in the Dynamic Conformal Arc Therapy, Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy of Lung Cancer.
PLoS One. 2015;10:e0144211.
PubMed Text format Abstract available

ADETIBA E, Olugbara OO
Improved Classification of Lung Cancer Using Radial Basis Function Neural Network with Affine Transforms of Voss Representation.
PLoS One. 2015;10:e0143542.
PubMed Text format Abstract available

SASI SP, Bae S, Song J, Perepletchikov A, et al
Correction: Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants.
PLoS One. 2015;10:e0144213.
PubMed Text format Abstract available

FISCELLA K, Winters P, Farah S, Sanders M, et al
Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics?
PLoS One. 2015;10:e0143789.
PubMed Text format Abstract available

JIN Y, Liu Y, Zhang J, Huang W, et al
The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer.
PLoS One. 2015;10:e0144187.
PubMed Text format Abstract available

ZHANG Y, Feng Y, Ahmad M, Ming X, et al
Intermediate Megavoltage Photon Beams for Improved Lung Cancer Treatments.
PLoS One. 2015;10:e0145117.
PubMed Text format Abstract available

ORLHAC F, Soussan M, Chouahnia K, Martinod E, et al
18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer.
PLoS One. 2015;10:e0145063.
PubMed Text format Abstract available

SUN H, Hu P, Shen H, Dong W, et al
Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
PLoS One. 2015;10:e0144663.
PubMed Text format Abstract available

TSAI JR, Liu PL, Chen YH, Chou SH, et al
Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-kappab/MMPs Signaling Pathway.
PLoS One. 2015;10:e0144462.
PubMed Text format Abstract available

KANG JI, Hong JY, Lee HJ, Bae SY, et al
Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
PLoS One. 2015;10:e0144368.
PubMed Text format Abstract available

DELAHAYE-SOURDEIX M, Oliver J, Timofeeva MN, Gaborieau V, et al
The 12p13.33/RAD52 locus and genetic susceptibility to squamous cell cancers of upper aerodigestive tract.
PLoS One. 2015;10:e0117639.
PubMed Text format Abstract available

HSU KH, Ho CC, Hsia TC, Tseng JS, et al
Identification of five driver gene mutations in patients with treatment-naive lung adenocarcinoma in Taiwan.
PLoS One. 2015;10:e0120852.
PubMed Text format Abstract available

KOCARNIK JM, Park SL, Han J, Dumitrescu L, et al
Pleiotropic and Sex-Specific Effects of Cancer GWAS SNPs on Melanoma Risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study.
PLoS One. 2015;10:e0120491.
PubMed Text format Abstract available

SILVA IT, Carvalho A, Lang KL, Dudek SE, et al
In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B.
PLoS One. 2015;10:e0117794.
PubMed Text format Abstract available

SRIRAM N, Mills J, Lang E, Dickson HK, et al
Attitudes and Stereotypes in Lung Cancer versus Breast Cancer.
PLoS One. 2015;10:e0145715.
PubMed Text format Abstract available

PHILLIPS M, Bauer TL, Cataneo RN, Lebauer C, et al
Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
PLoS One. 2015;10:e0142484.
PubMed Text format Abstract available

HYUN SH, Lee KH, Choi JY, Kim BT, et al
Influence of Body Mass Index on the Prognostic Value of Tumor (1)(8)F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
PLoS One. 2015;10:e0145020.
PubMed Text format Abstract available

MULLAPUDI N, Ye B, Suzuki M, Fazzari M, et al
Genome Wide Methylome Alterations in Lung Cancer.
PLoS One. 2015;10:e0143826.
PubMed Text format Abstract available

MORRISON A, Chekaluk Y, Bacares R, Ladanyi M, et al
BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
PLoS One. 2015;10:e0119224.
PubMed Text format Abstract available

CHIANG Y, Yang JC, Hsu FM, Chen YH, et al
The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases.
PLoS One. 2015;10:e0145936.
PubMed Text format Abstract available

CHATTOPADHYAY N, Berger AJ, Koenig E, Bannerman B, et al
KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
PLoS One. 2015;10:e0144825.
PubMed Text format Abstract available

MCKAY AJ, Patel RK, Majeed A
Strategies for tobacco control in India: a systematic review.
PLoS One. 2015;10:e0122610.
PubMed Text format Abstract available

CAO L, Tong H, Xu G, Liu P, et al
Systemic lupus erythematous and malignancy risk: a meta-analysis.
PLoS One. 2015;10:e0122964.
PubMed Text format Abstract available

MISHRA EK, Corcoran JP, Hallifax RJ, Stradling J, et al
Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
PLoS One. 2015;10:e0123798.
PubMed Text format Abstract available

CHIEN CH, Lee MJ, Liou HC, Liou HH, et al
Local Immunosuppressive Microenvironment Enhances Migration of Melanoma Cells to Lungs in DJ-1 Knockout Mice.
PLoS One. 2015;10:e0115827.
PubMed Text format Abstract available

SHAN L, Lian F, Guo L, Qiu T, et al
Detection of ROS1 gene rearrangement in lung adenocarcinoma: comparison of IHC, FISH and real-time RT-PCR.
PLoS One. 2015;10:e0120422.
PubMed Text format Abstract available

GROVE O, Berglund AE, Schabath MB, Aerts HJ, et al
Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma.
PLoS One. 2015;10:e0118261.
PubMed Text format Abstract available

HUANG AH, Pan SH, Chang WH, Hong QS, et al
PARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinoma.
PLoS One. 2015;10:e0118530.
PubMed Text format Abstract available

TSAY JC, Li Z, Yie TA, Wu F, et al
Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.
PLoS One. 2015;10:e0118132.
PubMed Text format Abstract available

REDANIEL MT, Martin RM, Ridd MJ, Wade J, et al
Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the clinical practice research datalink.
PLoS One. 2015;10:e0126608.
PubMed Text format Abstract available

PASDAR EA, Smits M, Stapelberg M, Bajzikova M, et al
Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents.
PLoS One. 2015;10:e0119549.
PubMed Text format Abstract available

PENG H, Ma J, Bai Y, Lu J, et al
MeDiA: Mean Distance Association and Its Applications in Nonlinear Gene Set Analysis.
PLoS One. 2015;10:e0124620.
PubMed Text format Abstract available

ANOTA A, Mouillet G, Trouilloud I, Dupont-Gossart AC, et al
Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
PLoS One. 2015;10:e0125350.
PubMed Text format Abstract available

CHU HL, Yip BS, Chen KH, Yu HY, et al
Novel antimicrobial peptides with high anticancer activity and selectivity.
PLoS One. 2015;10:e0126390.
PubMed Text format Abstract available

CAPPELLESSO R, Millioni R, Arrigoni G, Simonato F, et al
Lumican is overexpressed in lung adenocarcinoma pleural effusions.
PLoS One. 2015;10:e0126458.
PubMed Text format Abstract available

JAIN A, Lim C, Gan EM, Ng DZ, et al
Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
PLoS One. 2015;10:e0123587.
PubMed Text format Abstract available

KAMOMAE T, Monzen H, Nakayama S, Mizote R, et al
Accuracy of image guidance using free-breathing cone-beam computed tomography for stereotactic lung radiotherapy.
PLoS One. 2015;10:e0126152.
PubMed Text format Abstract available

D'ARCANGELO M, Todaro M, Salvini J, Benfante A, et al
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study.
PLoS One. 2015;10:e0125037.
PubMed Text format Abstract available

MISIC VV, Chan TC
The perils of adapting to dose errors in radiation therapy.
PLoS One. 2015;10:e0125335.
PubMed Text format Abstract available

CUNNIFF B, Newick K, Nelson KJ, Wozniak AN, et al
Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma.
PLoS One. 2015;10:e0127310.
PubMed Text format Abstract available

PENA N, Carrillo D, Munoz JP, Chnaiderman J, et al
Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells.
PLoS One. 2015;10:e0123029.
PubMed Text format Abstract available

HECHT SS, Koh WP, Wang R, Chen M, et al
Elevated levels of mercapturic acids of acrolein and crotonaldehyde in the urine of Chinese women in Singapore who regularly cook at home.
PLoS One. 2015;10:e0120023.
PubMed Text format Abstract available

SCHWEIGER T, Nikolowsky C, Starlinger P, Traxler D, et al
Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
PLoS One. 2015;10:e0120724.
PubMed Text format Abstract available

LIU L, Zhan P, Zhou X, Song Y, et al
Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.
PLoS One. 2015;10:e0117032.
PubMed Text format Abstract available

LIU J, Wan L, Lu K, Sun M, et al
The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
PLoS One. 2015;10:e0114586.
PubMed Text format Abstract available

LIN H, Kou B, Li X, Wang Y, et al
Grating-based phase-contrast imaging of tumor angiogenesis in lung metastases.
PLoS One. 2015;10:e0121438.
PubMed Text format Abstract available

ZANDVAKILI I, Davis AK, Hu G, Zheng Y, et al
Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.
PLoS One. 2015;10:e0127923.
PubMed Text format Abstract available

ZOLLNER S, Sokolnikov ME, Eidemuller M
Beyond two-stage models for lung carcinogenesis in the Mayak workers: implications for plutonium risk.
PLoS One. 2015;10:e0126238.
PubMed Text format Abstract available

FIGEAC F, Dagouassat M, Mahrouf-Yorgov M, Le Gouvello S, et al
Lung fibroblasts share mesenchymal stem cell features which are altered in chronic obstructive pulmonary disease via the overactivation of the Hedgehog signaling pathway.
PLoS One. 2015;10:e0121579.
PubMed Text format Abstract available

KLAMMER M, Dybowski JN, Hoffmann D, Schaab C, et al
Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib.
PLoS One. 2015;10:e0128542.
PubMed Text format Abstract available

PATTERSON SD, Rossi JM, Paweletz KL, Fitzpatrick VD, et al
Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.
PLoS One. 2015;10:e0122149.
PubMed Text format Abstract available

AMARAL FE, Parker D, Randis TM, Kulkarni R, et al
Rational Manipulation of mRNA Folding Free Energy Allows Rheostat Control of Pneumolysin Production by Streptococcus pneumoniae.
PLoS One. 2015;10:e0119823.
PubMed Text format Abstract available

DURRANS A, Gao D, Gupta R, Fischer KR, et al
Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC.
PLoS One. 2015;10:e0129123.
PubMed Text format Abstract available

PETERSON SW, Jurjevic Z, Frisvad JC
Expanding the species and chemical diversity of Penicillium section Cinnamopurpurea.
PLoS One. 2015;10:e0121987.
PubMed Text format Abstract available

ZHAO J, Ji G, Qiang Y, Han X, et al
A New Method of Detecting Pulmonary Nodules with PET/CT Based on an Improved Watershed Algorithm.
PLoS One. 2015;10:e0123694.
PubMed Text format Abstract available

YANG Y, Zhao Q, Cai Z, Cheng G, et al
Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of Fascin.
PLoS One. 2015;10:e0125132.
PubMed Text format Abstract available

HOOGENDAM JP, Zweemer RP, Verkooijen HM, de Jong PA, et al
No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer Patients.
PLoS One. 2015;10:e0131899.
PubMed Text format Abstract available

SATO M, Matsubara T, Adachi J, Hashimoto Y, et al
Differential Proteome Analysis Identifies TGF-beta-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model.
PLoS One. 2015;10:e0126483.
PubMed Text format Abstract available

CARBOGNIN L, Pilotto S, Milella M, Vaccaro V, et al
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
PLoS One. 2015;10:e0130142.
PubMed Text format Abstract available

HUANG JY, Jian ZH, Ndi Nfor O, Jhang KM, et al
The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
PLoS One. 2015;10:e0133367.
PubMed Text format Abstract available

IWASE S, Kawaguchi T, Tokoro A, Yamada K, et al
Assessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09).
PLoS One. 2015;10:e0134022.
PubMed Text format Abstract available

MARKOV OV, Mironova NL, Sennikov SV, Vlassov VV, et al
Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.
PLoS One. 2015;10:e0136911.
PubMed Text format Abstract available

MAHESWARAN E, Pedersen CB, Ditzel HJ, Gjerstorff MF, et al
Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer.
PLoS One. 2015;10:e0134967.
PubMed Text format Abstract available

HU K, Tang X, Tang G, Yao S, et al
18F-FP-PEG2-beta-Glu-RGD2: A Symmetric Integrin alphavbeta3-Targeting Radiotracer for Tumor PET Imaging.
PLoS One. 2015;10:e0138675.
PubMed Text format Abstract available

CALDERON LE, Liu S, Arnold N, Breakall B, et al
Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration.
PLoS One. 2015;10:e0143277.
PubMed Text format Abstract available

STAVRINOU P, Mavrogiorgou MC, Polyzoidis K, Kreft-Kerekes V, et al
Expression Profile of Genes Related to Drug Metabolism in Human Brain Tumors.
PLoS One. 2015;10:e0143285.
PubMed Text format Abstract available

ZHANG L, Wu C, Hoffman RM
Prostate Cancer Heterogeneous High-Metastatic Multi-Organ-Colonizing Chemo-Resistant Variants Selected by Serial Metastatic Passage in Nude Mice Are Highly Enriched for Multinucleate Giant Cells.
PLoS One. 2015;10:e0140721.
PubMed Text format Abstract available

MIN K, Ji B, Zhao M, Ji T, et al
Development of a Radiolabeled Peptide-Based Probe Targeting MT1-MMP for Breast Cancer Detection.
PLoS One. 2015;10:e0139471.
PubMed Text format Abstract available

January 2014

ZHOU Y, Rideout WM 3rd, Bressel A, Yalavarthi S, et al
Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy.
PLoS One. 2014;9:e105886.
PubMed Text format Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: